SCHEMBL5582769

SCHEMBL5582769

NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CN)C(=O)Nc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTMT1 Q9BV86 2/20 0.53
PDF Q9HBH1 1/20 0.52
F2 P00734 2/20 0.47
SSTR3 P32745 1/20 0.45
TACR1 P25103 1/20 0.44
KLKB1 P03952 1/20 0.44
PLG P00747 1/20 0.44
ACE P12821 3/20 0.43
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
FKBP4 Q02790 1/20 0.41
ITGB1 P05556 1/20 0.41
ITGA4 P13612 1/20 0.41
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11417445 0.94 NTMT1 (0.55) NTMT1PDFF2SSTR3TACR1
SCHEMBL11423847 0.91 NTMT1 (0.51) NTMT1PDFF2SSTR3TACR1
SCHEMBL1100531 0.89 PDF (0.49) NTMT1PDFF2SSTR3TACR1
SCHEMBL5874068 0.88 NTMT1 (0.44) NTMT1PDFF2TACR1HDAC3
Acetic Acid SCHEMBL7018491 0.86 TACR1 (0.43) NTMT1PDFSSTR3TACR1HDAC3
SCHEMBL263537 0.85 PDF (0.46) NTMT1PDFF2SSTR3TACR1
SCHEMBL29427848 0.85 PDF (0.46) NTMT1PDFF2SSTR3TACR1
SCHEMBL11418081 0.84 NTMT1 (0.47) NTMT1PDFF2SSTR3TACR1
Acetic Acid SCHEMBL16234756 0.84 PDF (0.44) NTMT1PDFF2SSTR3TACR1
Hydrochloric Acid SCHEMBL11425398 0.83 NTMT1 (0.46) NTMT1PDFF2SSTR3TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807082-A2 FACTOR XA COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 2007-07-18 EP disclosed
WO-2006047415-A2 FACTOR XA COMPOUNDS JANSSEN PHARMACEUTICA, N.V. (BE) 2006-05-04 WO disclosed
US-5223422-A T-PA MUTANT GK1L BOEHRINGER MANNHEIM GMBH (DE) 1993-06-29 US disclosed